Reduction of heat shock protein antibody levels by statin therapy

Lipids

Volumn 44, Issue 4, 2009, Pages 317-324

  Guisasola, María C ^a   Dulín, Elena ^a   Almendral, Jesús ^a   García Barreno, Pedro ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Atherosclerosis; Cholesterol; HMG CoA reductase; Hyperlypidemia; Immunology; Inflammation

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60 ANTIBODY; HEAT SHOCK PROTEIN 70 ANTIBODY; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOMODULATION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; ANTIBODIES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED;

EID: 63349098488     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-008-3265-3     Document Type: Article

References (26)

1. M Grau J Marrugat 2008 Risk functions and the primary prevention of cardiovascular disease Rev Esp Cardiol 61 404 416
2. Executive summary of the third report of the National Cholesterol Education Program (NCEP) 2001 Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285 2486 2497
3. K Skalen M Gustafsson EK Ryderg LM Hultén O Wiklund TL Innerarity J Borén 2002 Subendothelial retention of atherogenic lipoproteins in early atherosclerosis Nature 417 750 754
4. C Lahoz JM Mostaza 2007 La ateroesclerosis como enfermedad sistémica Rev Esp Cardiol 60 184 195
5. PH Jones 2001 Cholesterol: precursor to many lipid disorders Am J Manag Care 7 S289 S298
6. LA Alvarez-Sala M Calderon 2004 Colesterol, inflamación y ateroesclerosis: efectos antiinflamatorios de las estatinas Rev Clin Esp 204 18 29
7. G Weitz-Schmidt 2003 Lymphocyte function-associated antigen-1 blockade by statins: molecular basis and biological relevance Endothelium 10 43 47
8. LJ Jara G Medina O Vera-Lastra MC Amigo 2006 Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases Autoimmun Rev 5 195 201
9. CJ Binder K Hartvigsen M-K Chang M Miller D Brode W Palinski 2004 IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis J Clin Invest 114 427 437
10. TA Mehta J Greenman C Ettelaie A Venkatasubramaniam IC Chetter PT McCollum 2005 Heat shock proteins in vascular disease. A review Eur J Vasc Endovasc Surg 29 395 402
11. J George D Harats B Gilburd A Afek A Shaish J Kopolovic 2000 Adoptive transfer of beta (2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice Circulation 102 1822 1827
12. A Kol GK Sukhova AH Lichtman P Libby 1998 Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression Circulation 98 300 307
13. AG Pockley U De Faire R Kiessling C Lemne T Thulin J Frostegard 2002 Circulating heat shock proteins and heat shock proteins antibodies in established hypertension J Hypertens 20 1815 1820
14. YC Chan N Shukla M Abdus-Samee CS Berwanger J Stanford MM Singh 1999 Anti-heat-shock protein 70 kDa antibodies in vascular patients Eur J Vasc Endovasc Surg 18 381 385
15. K Mandal M Jahangiri Q Xu 2004 Autoimmunity to heat shock proteins in atherosclerosis Autoimmun Rev 3 31 37
16. Task Force Report 1998 Prevention of coronary disease in clinical practice. Recommendations of the Second Joint Task Force of European, other societies on coronary prevention Eur Heart J 19 1434 1503
17. Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Brudford EA, et al (2008) Guideline for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. doi: 10.1007/s12192-008-0068-7
18. DR Greaves KM Channon 2002 Inflammation and immune responses in atherosclerosis Trends Immunol 23 535 541
19. M Ghayour-Mobarban DJ Lamb DP Lovell C Livingstone T Wang GAA Ferns 2005 Plasma antibody titres to heat shock proteins-60, -65 and -70: their relationship to coronary risk factors in dyslipidaemic patients and healthy individuals Scand J Clin Lab Invest 65 601 614
20. DJ Lamb ML Tickner AC Dreux W El-Sankary SMO Hourani LJ Eales-Reynolds GAA Ferns 2004 Impairment of vascular function following BCG immunisation is associated with immune responses to HSP-60 in the cholesterol-fed rabbit Atherosclerosis 172 13 20
21. EUROASPIRE II Study Group 2001 Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II Euro Heart Survey Programme Eur Heart J 22 557 572
22. AM Gotto Jr JC LaRosa 2005 The benefits of statin therapy-what questions remain? Clin Cardiol 28 499 503
23. YO Shin JS Bae JB Lee JK Kim YJ Kim C Kim JK Ahn 2006 Effect of cardiac rehabilitation and statin treatment on anti-Hsp antibody titers in patients with coronary artery disease after percutaneous coronary intervention Int Heart J 47 671 682
24. G Weitz-Schmidt K Welzenbach V Brinkmann T Kamata J Kallen C Bruns 2001 Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site Nat Med 7 687 692
25. M Ortego C Bustos MA Hernández-Presa J Muñón C Díaz G Hernández 1999 Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells Atherosclerosis 147 253 261
26. G Taubes 2002 Cardiovascular disease. Does inflammation cut to the heart of the matter? Science 296 242 245